BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 27544741)

  • 1. The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins.
    Smith PK; Masilamani M; Li XM; Sampson HA
    J Allergy Clin Immunol; 2017 Feb; 139(2):429-437. PubMed ID: 27544741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do advanced glycation end-products cause food allergy?
    Smith PK
    Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):325-331. PubMed ID: 28786835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor Mediated Effects of Advanced Glycation End Products (AGEs) on Innate and Adaptative Immunity: Relevance for Food Allergy.
    Briceno Noriega D; Zenker HE; Croes CA; Ewaz A; Ruinemans-Koerts J; Savelkoul HFJ; van Neerven RJJ; Teodorowicz M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maillard reaction in food allergy: Pros and cons.
    Gupta RK; Gupta K; Sharma A; Das M; Ansari IA; Dwivedi PD
    Crit Rev Food Sci Nutr; 2018 Jan; 58(2):208-226. PubMed ID: 26980434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional effects of dietary advanced glycation end products.
    Miller JD
    J Allergy Clin Immunol; 2017 Jul; 140(1):319. PubMed ID: 28528927
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How dietary advanced glycation end products could facilitate the occurrence of food allergy.
    Paparo L; Coppola S; Nocerino R; Pisapia L; Picariello G; Cortese M; Voto L; Maglio M; Miele E; Carucci L; Oglio F; Trinchese G; Mollica MP; Bruno C; De Vita S; Tarallo A; Damiano C; Cerulo M; Esposito C; Fogliano V; Parenti G; Troncone R; Berni Canani R
    J Allergy Clin Immunol; 2024 Mar; 153(3):742-758. PubMed ID: 38042501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
    Prasad K; Tiwari S
    Curr Pharm Des; 2017; 23(6):937-943. PubMed ID: 27719648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do advanced glycation end products contribute to food allergy?
    Smith PK; Venter C; O'Mahony L; Canani RB; Lesslar OJL
    Front Allergy; 2023; 4():1148181. PubMed ID: 37081999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).
    Teodorowicz M; Hendriks WH; Wichers HJ; Savelkoul HFJ
    Front Immunol; 2018; 9():2088. PubMed ID: 30271411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
    Fotheringham AK; Gallo LA; Borg DJ; Forbes JM
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Advanced Glycation Endproducts Induce an Inflammatory Response in Human Macrophages in Vitro.
    van der Lugt T; Weseler AR; Gebbink WA; Vrolijk MF; Opperhuizen A; Bast A
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food advanced glycation end products as potential endocrine disruptors: An emerging threat to contemporary and future generation.
    Ravichandran G; Lakshmanan DK; Raju K; Elangovan A; Nambirajan G; Devanesan AA; Thilagar S
    Environ Int; 2019 Feb; 123():486-500. PubMed ID: 30622074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alarmins in Osteoporosis, RAGE, IL-1, and IL-33 Pathways: A Literature Review.
    De Martinis M; Ginaldi L; Sirufo MM; Pioggia G; Calapai G; Gangemi S; Mannucci C
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32204562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
    Leung SS; Forbes JM; Borg DJ
    Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the Maillard Reaction on the Allergenicity of Food Proteins and the Development of Allergic Inflammation.
    Toda M; Hellwig M; Henle T; Vieths S
    Curr Allergy Asthma Rep; 2019 Jan; 19(1):4. PubMed ID: 30689122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products.
    Fernando DH; Forbes JM; Angus PW; Herath CB
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.